apremilast

apremilast
Trade Name
Orphan Indication Behçet’s Disease
USA Market Approval USA
USA Designation Date 2013-01-17 00:00:00
Sponsor Celgene Corporation;86 Morris Avenue;Summit, New Jersey, 07901